# Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery

> **NCT04585620** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Allan Vestergaard Danielsen, MD** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Pain
- Post-thoracotomy Pain Syndrome
- Pain, Neuropathic
- Pain, Postoperative

## Interventions

- **DRUG:** Onabotulinum Toxin A
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04585620
- **Lead sponsor:** Allan Vestergaard Danielsen, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585620, "Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04585620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*